Condition
Mendelian Disorders
Total Trials
4
Recruiting
0
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Active Not Recruiting2
Completed1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT02021734CompletedPrimary
Genetics of Mendelian Diseases in Qatar
NCT05290701Active Not Recruiting
Evaluating Prenatal Exome Sequencing Study
NCT03211039Not ApplicableActive Not Recruiting
Perinatal Precision Medicine
NCT03589079UnknownPrimary
Delineation of Novel Monogenic Disorders in the United Arab Emirates Population
Showing all 4 trials